<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38961009</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2649</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation</Title><ISOAbbreviation>Qual Life Res</ISOAbbreviation></Journal><ArticleTitle>Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.</ArticleTitle><Pagination><StartPage>2489</StartPage><EndPage>2507</EndPage><MedlinePgn>2489-2507</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11136-024-03710-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Post COVID-19 Condition (PCC), being persistent COVID-19 symptoms, is reminiscent of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-a chronic multi-systemic illness characterised by neurocognitive, autonomic, endocrinological and immunological disturbances. This novel cross-sectional investigation aims to: (1) compare symptoms among people with ME/CFS (pwME/CFS) and people with PCC (pwPCC) to inform developing PCC diagnostic criteria; and (2) compare health outcomes between patients and people without acute or chronic illness (controls) to highlight the illness burdens of ME/CFS and PCC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sociodemographic and health outcome data were collected from n&#x2009;=&#x2009;61 pwME/CFS, n&#x2009;=&#x2009;31 pwPCC and n&#x2009;=&#x2009;54 controls via validated, self-administered questionnaires, including the 36-Item Short-Form Health Survey version 2 (SF-36v2) and World Health Organization Disability Assessment Schedule version 2.0 (WHODAS 2.0). PwME/CFS and pwPCC also provided self-reported severity and frequency of symptoms derived from the Canadian and International Consensus Criteria for ME/CFS and the World Health Organization case definition for PCC.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both illness cohorts similarly experienced key ME/CFS symptoms. Few differences in symptoms were observed, with memory disturbances, muscle weakness, lymphadenopathy and nausea more prevalent, light-headedness more severe, unrefreshed sleep more frequent, and heart palpitations less frequent among pwME/CFS (all p&#x2009;&lt;&#x2009;0.05). The ME/CFS and PCC participants' SF-36v2 or WHODAS 2.0 scores were comparable (all p&#x2009;&gt;&#x2009;0.05); however, both cohorts returned significantly lower scores in all SF-36v2 and WHODAS 2.0 domains when compared with controls (all p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This Australian-first investigation demonstrates the congruent and debilitating nature of ME/CFS and PCC, thereby emphasising the need for multidisciplinary care to maximise patient health outcomes.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weigel</LastName><ForeName>Breanna</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-8452-6656</Identifier><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coast, QLD, 4222, Australia. ncned@griffith.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, QLD, 4222, Australia. ncned@griffith.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, 4222, Australia. ncned@griffith.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eaton-Fitch</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-0815-3162</Identifier><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coast, QLD, 4222, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, QLD, 4222, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thapaliya</LastName><ForeName>Kiran</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7667-770X</Identifier><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coast, QLD, 4222, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, QLD, 4222, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall-Gradisnik</LastName><ForeName>Sonya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9270-2437</Identifier><AffiliationInfo><Affiliation>National Centre for Neuroimmunology and Emerging Diseases, Griffith University, Gold Coast, QLD, 4222, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium Health International for Myalgic Encephalomyelitis, Griffith University, Gold Coast, QLD, 4222, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>489798</GrantID><Agency>Stafford Fox Medical Research Foundation</Agency><Country/></Grant><Grant><GrantID>1199502</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>47107</GrantID><Agency>Mason Foundation</Agency><Country/></Grant><Grant><GrantID>49979</GrantID><Agency>McCusker Charitable Foundation</Agency><Country/></Grant><Grant><GrantID>4676</GrantID><Agency>Buxton Foundation</Agency><Country/></Grant><Grant><GrantID>4879</GrantID><Agency>Henty Community</Agency><Country/></Grant><Grant><GrantID>4579</GrantID><Agency>Blake Beckett Trust Foundation</Agency><Country/></Grant><Grant><GrantID>4570</GrantID><Agency>Alison Hunter Memorial Foundation</Agency><Country/></Grant><Grant><GrantID>4575</GrantID><Agency>Change for ME Charity</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Qual Life Res</MedlineTA><NlmUniqueID>9210257</NlmUniqueID><ISSNLinking>0962-9343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Post-Acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList><CoiStatement>The authors have no financial or non-financial competing interests relevant to the present manuscript to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>12</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>3</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38961009</ArticleId><ArticleId IdType="pmc">PMC11390810</ArticleId><ArticleId IdType="doi">10.1007/s11136-024-03710-3</ArticleId><ArticleId IdType="pii">10.1007/s11136-024-03710-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano, J. B., Allan, M., Alsokhn, C., Alwan, N. A., Askie, L., Davis, H. E., Diaz, J. V., Dua, T., De Groote, W., Jakob, R., Lado, M., Marshall, J., Murthy, S., Preller, J., Relan, P., Schiess, N., &amp; Seahwag, A. A. (2021). Clinical case definition of post COVID-19 condition by a Delphi consensus. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Nath, A. (2020). Long-haul COVID. Neurology,95, 559&#x2013;560. 10.1212/WNL.0000000000010640 10.1212/WNL.0000000000010640</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010640</ArticleId><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Moore Vogel, J., &amp; Topol, E. J. (2023). Long COVID: Major findings, mechanisms and recommendations. Nature Reviews Microbiology,21(3), 133&#x2013;146. 10.1038/s41579-022-00846-2 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as, C., Palacios-Ce&#xf1;a, D., G&#xf3;mez-Mayordomo, V., Florencio, L. L., Cuadrado, M. L., Plaza-Manzano, G., &amp; Navarro-Santana, M. (2021). Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. European Journal of Internal Medicine,92, 55&#x2013;70. 10.1016/j.ejim.2021.06.009 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch, J. B., Rengasamy, E. R., Watson, C., Jansen, K., Chakraborty, S., Sundaram, R. D., Hafeez, D., Burchill, E., Saini, A., Thomas, L., Cross, B., Hunt, C. K., Conti, I., Ralovska, S., Hussain, Z., Butler, M., Pollak, T. A., Koychev, I., Michael, B. D., &#x2026; Rooney, A. G. (2022). Persistent neuropsychiatric symptoms after COVID-19: A systematic review and meta-analysis. Brain Communications. 10.1093/braincomms/fcab297 10.1093/braincomms/fcab297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi, O. L., Hughes, S. E., Turner, G., Cruz Rivera, S., McMullan, C., Singh Chandan, J., Haroon, S., Price, G., Haf Davies, E., Nirantharakumar, K., Sapey, E., &amp; Calvert, M. J. (2021). Symptoms, complications, and management of Long COVID: A review. Journal of the Royal Society of Medicine,114(9), 428&#x2013;442. 10.1177/01410768211032850 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie, T., Hittle, M., &amp; Goodman, S. N. (2021). Assessment of the frequency and variety of persistent symptoms among patients with COVID-19&#x2014;A systematic review. JAMA Network Open,4(5), e2111417. 10.1001/jamanetworkopen.2021.11417 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk, J. (2022). Myalgic encephalomyelitis (chronic fatigue syndrome). BMJ Best Practice. Available from: https://bestpractice.bmj.com/topics/en-gb/277.</Citation></Reference><Reference><Citation>Sukocheva, O. A., Maksoud, R., Beeraka, N. M., Madhunapantula, S. V., Sinelnikov, M., Nikolenko, V. N., Neganova, M. E., Klochkov, S. G., Amjad Kamal, M., Staines, D. R., &amp; Marshall-Gradisnik, S. M. (2022). Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Advanced Research,40, 179&#x2013;196. 10.1016/j.jare.2021.11.013 10.1016/j.jare.2021.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik, S. M., &amp; Eaton-Fitch, N. (2022). Understanding myalgic encephalomyelitis. Science,377(6611), 1150&#x2013;1151. 10.1126/science.abo1261 10.1126/science.abo1261</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo1261</ArticleId><ArticleId IdType="pubmed">36074854</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C. P., Sherkey, J. A., &amp; Van de Sande, M. I. (2003). Myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Chronic Fatigue Syndrome,11(1), 7&#x2013;115. 10.1300/J092v11n01_0210.1300/J092v11n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers, B. M., Van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., Staines, D. R., Powles, A. C. P., Speight, N., Vallings, R., Bateman, L., Baumgarten-Austrheim, B., Bell, D. S., Carlo-Stella, N., Chia, J., Darragh, A., Jo, D., Lewis, D., Light, A. R., &#x2026; Stevens, S. (2011). Myalgic encephalomyelitis: International consensus criteria. Journal of Internal Medicine,270(4), 327&#x2013;338. 10.1111/j.1365-2796.2011.02428.x 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested, A. C., &amp; Marshall, L. M. (2015). Review of myalgic encephalomyelitis/chronic fatigue syndrome: An evidence-based approach to diagnosis and management by clinicians. Reviews on Environmental Health,30(4), 223&#x2013;249. 10.1515/reveh-2015-0026 10.1515/reveh-2015-0026</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2015-0026</ArticleId><ArticleId IdType="pubmed">26613325</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, L., Valencia, I. J., Garvert, D. W., &amp; Montoya, J. G. (2018). Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: A patient-centred, cross-sectional survey. PLoS ONE,13(6), e0197811. 10.1371/journal.pone.0197811 10.1371/journal.pone.0197811</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0197811</ArticleId><ArticleId IdType="pmc">PMC5983853</ArticleId><ArticleId IdType="pubmed">29856774</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff, A. L., &amp; Lipkin, W. I. (2021). Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends in Molecular Medicine,27(9), 895&#x2013;906. 10.1016/j.molmed.2021.06.002 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, T. L., &amp; Weitzer, D. J. (2021). Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;A systematic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas, Lithuania),57(5), 418. 10.3390/medicina57050418 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C. T., Arcos-Burgos, M., &amp; Lidbury, B. A. (2019). Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review. Diagnostics,9(3), 91. 10.3390/diagnostics9030091 10.3390/diagnostics9030091</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu, L., Valencia, I. J., Garvert, D. W., &amp; Montoya, J. G. (2019). Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Frontiers in Pediatrics,7, 12. 10.3389/fped.2019.00012 10.3389/fped.2019.00012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason, L. A., Islam, M. F., Conroy, K., Cotler, J., Torres, C., Johnson, M., &amp; Mabie, B. (2021). COVID-19 symptoms over time: Comparing long-haulers to ME/CFS. Fatigue: Biomedicine, Health &amp; Behavior,9(2), 59&#x2013;68. 10.1080/21641846.2021.192214010.1080/21641846.2021.1922140</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1922140</ArticleId><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul, L., O&#x2019;Boyle, S., Palla, L., Nacul, F. E., Mudie, K., Kingdon, C. C., Cliff, J. M., Clark, T. G., Dockrell, H. M., &amp; Lacerda, E. M. (2020). How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: The natural history of ME/CFS. Frontiers in Neurology. 10.3389/fneur.2020.00826 10.3389/fneur.2020.00826</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka, J., Jansari, V., Hornig, M., &amp; Iwasaki, A. (2022). Unexplained post-acute infection syndromes. Nature Medicine,28, 911&#x2013;923. 10.1038/s41591-022-01810-6 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, H., Kuo, C.-F., Yu, T.-S., Ke, L.-Y., Hung, C.-L., &amp; Tsai, S.-Y. (2023). Increased risk of chronic fatigue syndrome following infection: A 17-year population-based cohort study. Journal of Translational Medicine,21, 804. 10.1186/s12967-023-04636-z 10.1186/s12967-023-04636-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04636-z</ArticleId><ArticleId IdType="pmc">PMC10638797</ArticleId><ArticleId IdType="pubmed">37951920</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa, S., Nora-Krukle, Z., Henning, N., Eliassen, E., Shikova, E., Harrer, T., Scheibenbogen, C., Murovska, M., &amp; Prusty, B. K. (2018). Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine,16, 268. 10.1186/s12967-018-1644-y 10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova, E., Reshkova, V., Kumanova, A., Raleva, S., Alexandrova, D., Capo, N., Murovska, M., &amp; The European Network on ME/CFS (EUROMENE). (2020). Cytomegalovirus Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Medical Virology,92(12), 3682&#x2013;89. 10.1002/jmv.25744 10.1002/jmv.25744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason, L. A., Yoo, S., &amp; Bhatia, S. (2021). Patient perceptions of infectious illnesses preceding myalgic encephalomyelitis/chronic fatigue syndrome. Chronic Illness,18(4), 901&#x2013;910. 10.1177/17423953211043106 10.1177/17423953211043106</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17423953211043106</ArticleId><ArticleId IdType="pmc">PMC9152619</ArticleId><ArticleId IdType="pubmed">34541918</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason, L. A., Natelson, B. H., Bonilla, H., Sherif, Z. A., Vernon, S. D., Verduzco Gutierrez, M., O&#x2019;Brien, L., &amp; Taylor, E. (2023). What Long COVID investigators can learn from four decades of ME/CFS research. Brain Behavior and Immunity Integrative,4, 100022. 10.1016/j.bbii.2023.10002210.1016/j.bbii.2023.100022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbii.2023.100022</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini Sasso, E., Muraki, K., Eaton-Fitch, N., Smith, P., Lesslar, O. L., Deed, G., &amp; Marshall-Gradisnik, S. M. (2022). Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients. Molecular Medicine,28(1), 98. 10.1186/s10020-022-00528-y 10.1186/s10020-022-00528-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-022-00528-y</ArticleId><ArticleId IdType="pmc">PMC9388968</ArticleId><ArticleId IdType="pubmed">35986236</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya, K., Marshall-Gradisnik, S. M., Barth, M., Eaton-Fitch, N., &amp; Barnden, L. (2023). Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients. Frontiers in Neuroscience. 10.3389/fnins.2023.1125208 10.3389/fnins.2023.1125208</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1125208</ArticleId><ArticleId IdType="pmc">PMC10017877</ArticleId><ArticleId IdType="pubmed">36937672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes, L. D., Sanal-Hayes, N. E. M., Mclaughlin, M., Berry, E. C. J., &amp; Sculthorpe, N. F. (2023). People with long COVID and ME/CFS exhibit similarly impaired balance and physical capacity: A case-case-control study. American Journal of Medicine. 10.1016/j.amjmed.2023.06.028 10.1016/j.amjmed.2023.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.06.028</ArticleId><ArticleId IdType="pubmed">37490948</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen, C. L. M. C., Rowe, P. C., &amp; Visser, F. C. (2022). Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: Similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina,58(1), 28. 10.3390/medicina5801002810.3390/medicina58010028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Sivan, M., Delaney, B., Evans, R., &amp; Milne, R. (2022). Long COVID&#x2014;An update for primary care. BMJ,378, e072117. 10.1136/bmj-2022-072117 10.1136/bmj-2022-072117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook, H., Raza, S., Nowell, J., Young, M., &amp; Edison, P. (2021). Long COVID&#x2014;Mechanisms, risk factors, and management. BMJ,374, n1648. 10.1136/bmj.n1648 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru, S., &amp; Merad, M. (2022). Pathological sequelae of long-haul COVID. Nature Immunology,23, 194&#x2013;202. 10.1038/s41590-021-01104-y 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud, R., Magawa, C., Eaton-Fitch, N., Thapaliya, K., &amp; Marshall-Gradisnik, S. M. (2023). Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review. BMC Medicine,21, 189. 10.1186/s12916-023-02893-9 10.1186/s12916-023-02893-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02893-9</ArticleId><ArticleId IdType="pmc">PMC10206551</ArticleId><ArticleId IdType="pubmed">37226227</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. (2023) Scottish Intercollegiate Guidelines Network, and Royal College of General Practitioners. COVID-19 rapid guideline: Managing the long-term effects of COVID-19. Available from: https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Srikanth, S., Boulos, J. R., Dover, T., Boccuto, L., &amp; Dean, D. (2023). Identification and diagnosis of long COVID-19: A scoping review. Progress in Biophysics and Molecular Biology,182, 1&#x2013;7. 10.1016/j.pbiomolbio.2023.04.008 10.1016/j.pbiomolbio.2023.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2023.04.008</ArticleId><ArticleId IdType="pmc">PMC10176974</ArticleId><ArticleId IdType="pubmed">37182545</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin, D., Moschopoulos, C. D., Margalit, I., Gkrania-Klotsas, E., Landi, F., Stahl, J.-P., &amp; Yahav, D. (2022). ESCMID rapid guidelines for assessment and management of long COVID. Clinical Microbiology &amp; Infection,28(7), 955&#x2013;972. 10.1016/j.cmi.2022.02.018 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai, T., Jolley, S. E., Karlson, E. W., Levitan, E. B., Levy, B., McComsey, G. A., McCorkell, L., Nadkarni, G. N., Parthasarathy, S., Singh, U., Walker, T. A., Selvaggi, C. A., Shinnick, D. J., Schulte, C. C. M., Atchley-Challenner, R., Horwitz, L. I., Foulkes, A. S., &amp; Recover Consortium Authors. (2023). Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA,329(22), 1934&#x2013;1946. 10.1001/jama.2023.8823 10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Basharat, S., Chao, Y.-S., &amp; McGill, S. C. (2022). Subtypes of post-COVID-19 condition: A review of the emerging evidence. In: CADTH Health Technology Review Canadian agency for drugs and technologies in health: Ottawa, Canada. Available from: https://www.ncbi.nlm.nih.gov/books/NBK601826/.</Citation><ArticleIdList><ArticleId IdType="pubmed">38507533</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff, A. L., &amp; Lipkin, W. I. (2023). ME/CFS and long COVID share similar symptoms and biological abnormalities: Road map to the literature. Frontiers in Medicine,10, 1187163. 10.3389/fmed.2023.1187163 10.3389/fmed.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey, Q., Sheikh, A., Daines, L., &amp; Vasileiou, E. (2022). Symptoms and signs of long COVID: A rapid review and meta-analysis. Journal of Global Health,12, 05014. 10.7189/jogh.12.05014 10.7189/jogh.12.05014</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., &amp; Villapol, S. (2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Science and Reports,11, 16144. 10.1038/s41598-021-95565-810.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan, A., Shetty, A., Delanerolle, G., Zeng, Y., Zhang, Y., Raymont, V., Rathod, S., Halabi, S., Elliot, K., Shi, J. Q., &amp; Phiri, P. (2023). A systematic review and meta-analysis of long COVID symptoms. Systematic Reviews,12, 88. 10.1186/s13643-023-02250-0 10.1186/s13643-023-02250-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Retornaz, F., Rebaudet, S., Stavris, C., &amp; Jammes, Y. (2022). Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: Results of the retrospective CoLGEM study. Journal of Translational Medicine,20(1), 429. 10.1186/s12967-022-03638-7 10.1186/s12967-022-03638-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03638-7</ArticleId><ArticleId IdType="pmc">PMC9509619</ArticleId><ArticleId IdType="pubmed">36153556</ArticleId></ArticleIdList></Reference><Reference><Citation>Azcue, N., G&#xf3;mez-Esteban, J. C., Acera, M., Tijero, B., Fernandez, T., Ayo-Mentxakatorre, N., P&#xe9;rez-Concha, T., Murueta-Goyena, A., Lafuente, J. V., Prada, &#xc1;., de Munain, A. L., Ruiz-Irastorza, G., Ribacoba, L., Gabilondo, I., &amp; Del Pino R. Brain fog of Post-COVID-19. (2022). Condition and chronic fatigue syndrome, same medical disorder? Journal of Translational Medicine,20(1), 569. 10.1186/s12967-022-03764-2 10.1186/s12967-022-03764-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03764-2</ArticleId><ArticleId IdType="pmc">PMC9724286</ArticleId><ArticleId IdType="pubmed">36474290</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon, S. D., Hartle, M., Sullivan, K., Bell, J., Abbaszadeh, S., Unutmaz, D., &amp; Bateman, L. (2023). Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work,74(4), 1179&#x2013;1186. 10.3233/WOR-220581 10.3233/WOR-220581</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220581</ArticleId><ArticleId IdType="pubmed">36911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor, C., Freitag, H., Meyer-Arndt, L., Wittke, K., Hanitsch, L. G., Zoller, T., Steinbeis, F., Haffke, M., Rudolf, G., Heidecker, B., Bobbert, T., Spranger, J., Volk, H.-D., Skurk, C., Konietschke, F., Paul, F., Behrends, U., Bellmann-Strobl, J., &amp; Scheibenbogen, C. (2022). A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature Communications,13(1), 5104. 10.1038/s41467-022-32507-6 10.1038/s41467-022-32507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt, J., Blease, C., &amp; Geraghty, K. J. (2022). Long COVID at the crossroads: Comparisons and lessons from the treatment of patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Journal of Health Psychology,27(14), 3106&#x2013;3120. 10.1177/13591053221084494 10.1177/13591053221084494</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053221084494</ArticleId><ArticleId IdType="pubmed">35341334</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroti, D., &amp; Bileviciute-Ljungar, I. (2018). Similarities and differences between health-related quality of life in patients with exhaustion syndrome and chronic fatigue syndrome. Fatigue: Biomedicine, Health &amp; Behavior,6(4), 208&#x2013;19. 10.1080/21641846.2018.151558310.1080/21641846.2018.1515583</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2018.1515583</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves de Sousa, K. C., Gardel, D. G., &amp; Lopes, A. J. (2022). Postural balance and its association with functionality and quality of life in non-hospitalized patients with post-acute COVID-19 syndrome. Physiotherapy Research International,27(4), e1967. 10.1002/pri.1967 10.1002/pri.1967</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pri.1967</ArticleId><ArticleId IdType="pmc">PMC9349853</ArticleId><ArticleId IdType="pubmed">35842844</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvache-Mateo, A., L&#xf3;pez-L&#xf3;pez, L., Mart&#xed;n-N&#xfa;&#xf1;ez, J., Heredia-Ciur&#xf3;, A., Granados-Santiago, M., Ortiz-Rubio, A., &amp; Valenza, M. C. (2023). Pain and clinical presentation: A cross-sectional study of patients with new-onset chronic pain in long-COVID-19 syndrome. International Journal of Environmental Research and Public Health. 10.3390/ijerph20054049 10.3390/ijerph20054049</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20054049</ArticleId><ArticleId IdType="pmc">PMC10001485</ArticleId><ArticleId IdType="pubmed">36901059</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston, S. C., Brenu, E. W., Hardcastle, S. L., Huth, T. K., Staines, D. R., &amp; Marshall-Gradisnik, S. M. (2014). A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis. Health and Quality of Life Outcomes,12(1), 64. 10.1186/1477-7525-12-64 10.1186/1477-7525-12-64</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-12-64</ArticleId><ArticleId IdType="pmc">PMC4008489</ArticleId><ArticleId IdType="pubmed">24886213</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, C.-J., Hung, L.-Y., Kogelnik, A. M., Kaufman, D., Aiyar, R. S., Chu, A. M., Wilhelmy, J., Li, P., Tannenbaum, L., Xiao, W., &amp; Davis, R. W. (2021). A comprehensive examination of severely ill ME/CFS patients. Healthcare. 10.3390/healthcare9101290 10.3390/healthcare9101290</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9101290</ArticleId><ArticleId IdType="pmc">PMC8535418</ArticleId><ArticleId IdType="pubmed">34682970</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rster, C., Colomba, M. G., Wetzel, A.-J., &amp; Joos, S. (2022). Persisting symptoms after COVID-19&#x2014;Prevalence and risk factors in a population-based cohort. Deutsches &#xc4;rzteblatt International,119, 167&#x2013;174. 10.3238/arztebl.m2022.0147 10.3238/arztebl.m2022.0147</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2022.0147</ArticleId><ArticleId IdType="pmc">PMC9215272</ArticleId><ArticleId IdType="pubmed">35236547</ArticleId></ArticleIdList></Reference><Reference><Citation>Giszas, B., Trommer, S., Sch&#xfc;&#xdf;ler, N., Rodewald, A., Besteher, B., Bleidorn, J., Dickmann, P., Finke, K., Katzer, K., Lehmann-Pohl, K., Lemh&#xf6;fer, C., Pletz, M. W., Puta, C., Quickert, S., Walter, M., Stallmach, A., &amp; Reuken, P. A. (2023). Post-COVID-19 condition is not only a question of persistent symptoms: Structured screening including health-related quality of life reveals two separate clusters of post-COVID. Infection,51, 365&#x2013;377. 10.1007/s15010-022-01886-9 10.1007/s15010-022-01886-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01886-9</ArticleId><ArticleId IdType="pmc">PMC9307219</ArticleId><ArticleId IdType="pubmed">35869353</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirotiak, Z., Thomas, E. B. K., &amp; Brellenthin, A. G. (2023). Stress, anxiety, and depression severity among individuals with no history, previous history, or current history of long COVID. Journal of Psychosomatic Research,175, 111519. 10.1016/j.jpsychores.2023.111519 10.1016/j.jpsychores.2023.111519</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111519</ArticleId><ArticleId IdType="pubmed">37832276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme, M., Braillard, O., Chappuis, F., CoviCare Study Team, and Guessous I. (2022). The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment, and increased healthcare utilization. Scientific Reports,12, 14505. 10.1038/s41598-022-18673-z 10.1038/s41598-022-18673-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18673-z</ArticleId><ArticleId IdType="pmc">PMC9403954</ArticleId><ArticleId IdType="pubmed">36008436</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspar, P., Dias, M., Parreira, I., Gon&#xe7;alves, H. D., Parlato, F., Maione, V., Atalaia Barbacena, H., Carreiro, C., &amp; Duarte, L. (2023). Predictors of long-COVID-19 and its impact on quality of life: Longitudinal analysis at 3, 6, and 9 months after discharge from a Portuguese centre. Acta M&#xe9;dica Portuguesa,36(10), 647&#x2013;60. 10.20344/amp.19047 10.20344/amp.19047</Citation><ArticleIdList><ArticleId IdType="doi">10.20344/amp.19047</ArticleId><ArticleId IdType="pubmed">36827994</ArticleId></ArticleIdList></Reference><Reference><Citation>Biddle, N., &amp; Korda, R. (2023). The experience of COVID-19 in Australia, including Long-COVID&#x2014;Evidence from the COVID-19 Impact Monitoring Survey Series, August 2022. Available from: https://csrm.cass.anu.edu.au/research/publications/experience-covid-19-australia-including-long-covid-evidence-covid-19-impact.</Citation></Reference><Reference><Citation>Strand, E. B., Marit Mengshoel, A., Sandvik, L., Helland, I. B., Abraham, S., &amp; Solberg, N. L. (2019). Pain is associated with reduced quality of life and functional status in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Scandinavian Journal of Pain,19(1), 61&#x2013;72. 10.1515/sjpain-2018-0095 10.1515/sjpain-2018-0095</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/sjpain-2018-0095</ArticleId><ArticleId IdType="pubmed">30325738</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly, A., &amp; Buchanan, R. (2023). ME/CFS national disability agreement review submission. Available from: https://www.pc.gov.au/__data/assets/pdf_file/0004/230953/sub023-disability-agreement.pdf.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as, C., Mart&#xed;n-Guerrero, J. D., Cancela-Cilleruelo, I., Moro-L&#xf3;pez-Menchero, P., Rodr&#xed;guez-Jim&#xe9;nez, J., Navarro-Pardo, E., &amp; Pellicer-Valero, O. J. (2022). Exploring the recovery curves for long-term post-COVID functional limitations on daily living activities: The Long-COVID-Exp-CM multicenter study. Journal of Infection,84(5), 722&#x2013;746. 10.1016/j.jinf.2022.01.031 10.1016/j.jinf.2022.01.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.031</ArticleId><ArticleId IdType="pmc">PMC8801977</ArticleId><ArticleId IdType="pubmed">35101537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain, M. M., Das, J., Rahman, F., Nesa, F., Hossain, P., Islam, A. M. K., Tasnim, S., Faizah, F., Mazumder, H., Purohit, N., &amp; Ramirez, G. (2023). Living with &#x201c;Long COVID&#x201d;: A systematic review and meta-synthesis of qualitative evidence. PLoS ONE,18(2), e0281884. 10.1371/journal.pone.0281884 10.1371/journal.pone.0281884</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281884</ArticleId><ArticleId IdType="pmc">PMC9934341</ArticleId><ArticleId IdType="pubmed">36795701</ArticleId></ArticleIdList></Reference><Reference><Citation>House of Representatives Standing Committee on Health. (2023). Aged Care, and Sport. Sick and tired: Casting a long shadow&#x2014;Inquiry into long COVID and repeated COVID-19 infections. Commonwealth of Australia: Canberra, Australia. Available from: https://parlinfo.aph.gov.au/parlInfo/download/committees/reportrep/RB000006/toc_pdf/SickandtiredCastingalongshadow.pdf.</Citation></Reference><Reference><Citation>Sorrell, T. C., Hensher, M., &amp; Sanci, L. A. (2023). Long COVID in Australia: Achieving equitable access to supportive health care. Medical Journal of Australia,218(10), 455&#x2013;457. 10.5694/mja2.51950 10.5694/mja2.51950</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.51950</ArticleId><ArticleId IdType="pubmed">37164340</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho Leite, J. C., De Lourdes, D. M., Killett, A., Kale, S., Nacul, L. C., McArthur, M., Hong, C. S., O&#x2019;Driscoll, L., Pheby, D. F. H., Campion, P., &amp; Lacerda, E. M. (2011). Social support needs for equity in health and social care: A thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis. International Journal for Equity in Health,10, 46. 10.1186/1475-9276-10-46 10.1186/1475-9276-10-46</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-9276-10-46</ArticleId><ArticleId IdType="pmc">PMC3229491</ArticleId><ArticleId IdType="pubmed">22044797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone, T., Taylor, A. K., O&#x2019;Donnell, C. A., Atherton, H., Blane, D. N., &amp; Chew-Graham, C. A. (2020). Finding the &#x201c;right&#x201d; GP: A qualitative study of the experiences of people with Long-COVID. BJGP Open. 10.3399/bjgpopen20X101143 10.3399/bjgpopen20X101143</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunnquist, M., Nicholson, L., Jason, L. A., &amp; Friedman, K. J. (2017). Access to medical care for individuals with myalgic encephalomyelitis and chronic fatigue syndrome: A call for centers of excellence. Modern Clinical Medicine Research,1(1), 28&#x2013;35. 10.22606/mcmr.2017.11005 10.22606/mcmr.2017.11005</Citation><ArticleIdList><ArticleId IdType="doi">10.22606/mcmr.2017.11005</ArticleId><ArticleId IdType="pmc">PMC5510655</ArticleId><ArticleId IdType="pubmed">28713878</ArticleId></ArticleIdList></Reference><Reference><Citation>Melby, L., &amp; Das Nair, R. (2023). &#x201c;We have no services for you so you&#x2026; have to make the best out of it&#x201d;: A qualitative study of myalgic encephalomyelitis/chronic fatigue syndrome patients&#x2019; dissatisfaction with healthcare services. Health Expect,27(1), e13900. 10.1111/hex.13900 10.1111/hex.13900</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.13900</ArticleId><ArticleId IdType="pmc">PMC10726260</ArticleId><ArticleId IdType="pubmed">37905602</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel, B., &amp; Haddock, R. (2023). How patient experiences can guide the development of long COVID health policy. 10.25916/b246-r560.</Citation></Reference><Reference><Citation>Eaton-Fitch, N., Johnston, S. C., Zalewski, P., Staines, D. R., &amp; Marshall-Gradisnik, S. M. (2020). Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: An Australian cross-sectional study. Quality of Life Research,29(6), 1521&#x2013;1531. 10.1007/s11136-019-02411-6 10.1007/s11136-019-02411-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-019-02411-6</ArticleId><ArticleId IdType="pmc">PMC7253372</ArticleId><ArticleId IdType="pubmed">31970624</ArticleId></ArticleIdList></Reference><Reference><Citation>LimeSurvey GmbH. (2003). LimeSurvey: An open source survey tool. Hamburg, Germany: LimeSurvey GmbH. Available from: http://www.limesurvey.org.</Citation></Reference><Reference><Citation>National Health and Medical Research Council and Australian Research Council. (2007). National statement on ethical conduct in human research. Available from: https://www.nhmrc.gov.au/about-us/publications/national-statement-ethical-conduct-human-research-2007-updated-2018.</Citation></Reference><Reference><Citation>World Medical Association. (2013). World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA,310(20), 2191&#x2013;2194. 10.1001/jama.2013.281053 10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., G&#xf8;tzsche, P. C., &amp; Vandenbroucke, J. P. (2008). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Journal of Clinical Epidemiology,61(4), 344&#x2013;349. 10.1016/j.jclinepi.2007.11.008 10.1016/j.jclinepi.2007.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2007.11.008</ArticleId><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner, D., Nisenbaum, R., Heim, C., Jones, J. F., Unger, E. R., &amp; Reeves, W. C. (2005). Psychometric properties of the CDC symptom inventory for assessment of chronic fatigue syndrome. Population Health Metrics,3(1), 8. 10.1186/1478-7954-3-8 10.1186/1478-7954-3-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1478-7954-3-8</ArticleId><ArticleId IdType="pmc">PMC1183246</ArticleId><ArticleId IdType="pubmed">16042777</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware, J. E., Jr. (2000). SF-36 health survey update. Spine,25(24), 3130&#x2013;3139. 10.1097/00007632-200012150-00008 10.1097/00007632-200012150-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-200012150-00008</ArticleId><ArticleId IdType="pubmed">11124729</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;st&#xfc;n, T. B., Kostanjsek, N., Chatterji, S., Rehm, J., &amp; World Health Organization. (2010). Measuring health and disability: Manual for WHO disability assessment schedule (WHODAS 2.0). Available from: https://www.who.int/publications/i/item/measuring-health-and-disability-manual-for-who-disability-assessment-schedule-(-whodas-2.0).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2971503</ArticleId><ArticleId IdType="pubmed">21076562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond, A. S., &amp; Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica,67(6), 361&#x2013;370. 10.1111/j.1600-0447.1983.tb09716.x 10.1111/j.1600-0447.1983.tb09716.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Multiple Sclerosis Clinical Practice Guidelines. (1998). Fatigue and multiple sclerosis: Evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America: Washington D.C., United States. Available from: https://pva.org/wp-content/uploads/2021/09/fatigue1b772.pdf.</Citation></Reference><Reference><Citation>Bell, D.S. (1995). The doctor&#x2019;s guide to chronic fatigue syndrome: Understanding, treating, and living with CFIDS.</Citation></Reference><Reference><Citation>IBM Corp. (2022). IBM statistical package for the social sciences (SPSS) statistics for windows, Version 29.0. Armonk, New York: IBM Corp.</Citation></Reference><Reference><Citation>Lang, T. A., &amp; Altman, D. G. (2013). Basic statistical recording for articles published in biomedical journals; The statistical analyses and methods in the published literature&#x201d; or &#x201c;The SAMPL guidelines. In P. Smart, H. Maisonneuve, &amp; A. Polderman (Eds.), Science editor&#x2019;s handbook. European Association of Science. Available from:&#xa0;https://www.equator-network.org/wp-content/uploads/2013/07/SAMPL-Guidelines-6-27-13.pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">25441757</ArticleId></ArticleIdList></Reference><Reference><Citation>Stensen, K., &amp; Lydersen, S. (2022). Internal consistency: From alpha to omega. Tidsskr Nor Laegeforen. 10.4045/tidsskr.22.0112 10.4045/tidsskr.22.0112</Citation><ArticleIdList><ArticleId IdType="doi">10.4045/tidsskr.22.0112</ArticleId><ArticleId IdType="pubmed">36066232</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., &amp; Komaroff, A. (1994). The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine,121(12), 953&#x2013;959. 10.7326/0003-4819-121-12-199412150-00009 10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey, R., DeMars, J., Franklin, K., Culos-Reed, S. N., Weatherald, J., &amp; Wrightson, J. G. (2022). Chronic fatigue and postexertional malaise in people living with Long COVID: An observational study. Physical Therapy. 10.1093/ptj/pzac005 10.1093/ptj/pzac005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla, H., Quach, T. C., Tiwari, A., Bonilla, A. E., Miglis, M., Yang, P. C., Eggert, L. E., Sharifi, H., Horomanski, A., Subramanian, A., Smirnoff, L., Simpson, N., Halawi, H., Sum-Ping, O., Kalinowski, A., Patel, Z. M., Shafer, R. W., &amp; Geng, L. N. (2023). Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic. Frontiers in Neurology. 10.3389/fneur.2023.1090747 10.3389/fneur.2023.1090747</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="pubmed">36908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu, K., Honda, H., Sunada, N., Sakurada, Y., Matsuda, Y., Yamamoto, K., Nakano, Y., Hasegawa, T., Yamamoto, Y., Otsuka, Y., Hagiya, H., Kataoka, H., Ueda, K., &amp; Otsuka, F. (2022). Clinical characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosed in patients with long COVID. Medicina (Lithuania). 10.3390/medicina5807085010.3390/medicina58070850</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>AlMuhaissen, S., Abu Libdeh, A., ElKhatib, Y., Alshayeb, R., Jaara, A., &amp; Bardaweel, S. K. (2023). Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: Is there a connection? Current Medical Research and Opinion,39(8), 1119&#x2013;1126. 10.1080/03007995.2023.2242244 10.1080/03007995.2023.2242244</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2023.2242244</ArticleId><ArticleId IdType="pubmed">37501626</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, E.-J., &amp; Son, C.-G. (2020). Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine,18(1), 289. 10.1186/s12967-020-02455-0 10.1186/s12967-020-02455-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Aly, M. A. E. G., &amp; Saber, H. G. (2021). Long COVID and chronic fatigue syndrome: A survey of elderly female survivors in Egypt. International Journal of Clinical Practice,75(12), e14886. 10.1111/ijcp.14886 10.1111/ijcp.14886</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14886</ArticleId><ArticleId IdType="pmc">PMC8646426</ArticleId><ArticleId IdType="pubmed">34537995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli, C., Zocchi, C., Tassetti, L., Silverii, M. V., Amato, C., Livi, L., Giovannoni, L., Verrillo, F., Bartoloni, A., Marcucci, R., Lavorini, F., Fumagalli, S., Ungar, A., Olivotto, I., Rasero, L., Fattirolli, F., Marchionni, N., &amp; AOU Careggi COVID-19 Follow-up study Group. (2022). Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. European Journal of Internal Medicine,97, 36&#x2013;41. 10.1016/j.ejim.2021.11.018 10.1016/j.ejim.2021.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, L., Yao, Q., Gu, X., Wang, Q., Ren, L., Wang, Y., Hu, P., Guo, L., Liu, M., Xu, J., Zhang, X., Qu, Y., Fan, Y., Li, X., Li, C., Yu, T., Xia, J., Wei, M., Chen, L., &#x2026; Cao, B. (2021). 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. The Lancet,398(10302), 747&#x2013;758. 10.1016/S0140-6736(21)01755-410.1016/S0140-6736(21)01755-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns, R., &amp; Hotopf, M. (2005). A systematic review describing the prognosis of chronic fatigue syndrome. Occupational Medicine (London),55(1), 20&#x2013;31. 10.1093/occmed/kqi01310.1093/occmed/kqi013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensher, M., Angeles, M. R., De Graaff, B., Campbell, J., Athan, E., &amp; Haddock, R. (2023). Managing the long term health consequences of COVID-19 in Australia. Available from: https://ahha.asn.au/publication/health-policy-issue-briefs/deeble-issues-brief-no-40-managing-long-term-health.</Citation></Reference><Reference><Citation>Al-Aly, Z., Bowe, B., &amp; Xie, Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nature Medicine,28(7), 1461&#x2013;1467. 10.1038/s41591-022-01840-0 10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ireson, J., Taylor, A., Richardson, E., Greenfield, B., &amp; Jones, G. (2022). Exploring invisibility and epistemic injustice in Long COVID&#x2014;A citizen science qualitative analysis of patient stories from an online COVID community. Health Expectations,25(4), 1753&#x2013;1765. 10.1111/hex.13518 10.1111/hex.13518</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.13518</ArticleId><ArticleId IdType="pmc">PMC9327841</ArticleId><ArticleId IdType="pubmed">35557480</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell, D., Spence, N. J., Chase, J.-A.D., Schwartz, T., Tumminello, C. M., &amp; Bouldin, E. (2022). Support amid uncertainty: Long COVID illness experiences and the role of online communities. SSM Qualitative Research in Health,2, 100177. 10.1016/j.ssmqr.2022.100177 10.1016/j.ssmqr.2022.100177</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ssmqr.2022.100177</ArticleId><ArticleId IdType="pmc">PMC9531408</ArticleId><ArticleId IdType="pubmed">36212783</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch, N., Du Preez, S., Cabanas, H., Muraki, K., Staines, D. R., &amp; Marshall-Gradisnik, S. M. (2022). Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients. Journal of Translational Medicine,20(1), 94. 10.1186/s12967-022-03297-8 10.1186/s12967-022-03297-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03297-8</ArticleId><ArticleId IdType="pmc">PMC8848670</ArticleId><ArticleId IdType="pubmed">35172836</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapaliya, K., Staines, D. R., Marshall-Gradisnik, S. M., Su, J., &amp; Barnden, L. (2022). Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Neuroscience Research,100(7), 1476&#x2013;1486. 10.1002/jnr.25048 10.1002/jnr.25048</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.25048</ArticleId><ArticleId IdType="pmc">PMC9321967</ArticleId><ArticleId IdType="pubmed">35355311</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, J., Thapaliya, K., Eaton-Fitch, N., Marshall-Gradisnik, S. M., &amp; Barnden, L. (2023). Connectivity between salience and default mode networks and subcortical nodes distinguishes between two classes of myalgic encephalomyelitis/chronic fatigue syndrome. Brain Connectivity,13(3), 164&#x2013;173. 10.1089/brain.2022.0049 10.1089/brain.2022.0049</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/brain.2022.0049</ArticleId><ArticleId IdType="pubmed">36352819</ArticleId></ArticleIdList></Reference><Reference><Citation>Strand, E. B., Nacul, L., Marit Mengshoel, A., Helland, I. B., Grabowski, P., Krumina, A., Alegre-Martin, J., Efrim-Budisteanu, M., Sekulic, S., Pheby, D. F. H., Sakkas, G. K., Adella Sirbu, C., Authier, F. J., &amp; European Network on ME/CFS (EUROMENE). (2019). Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union. PLoS One,14(12), e0225995. 10.1371/journal.pone.0225995 10.1371/journal.pone.0225995</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0225995</ArticleId><ArticleId IdType="pmc">PMC6894853</ArticleId><ArticleId IdType="pubmed">31805176</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>